Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Centocor ties into GeneNews osteoarthritis program
January 2009
SHARING OPTIONS:

TORONTO—GeneNews Ltd., a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, in December entered into a agreement allowing Centocor Research & Development Inc. selected access to research from its osteoarthritis genomic biomarker program. Centocor is a biomedicine-oriented company that seeks innovative ways to treat cancer and immune-mediated inflammatory disorders, such as rheumatoid arthritis and plaque psoriasis. Financial and other terms of the agreement were not disclosed. DDN

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.